Prognostic Significance of Beclin-1 Expression in Colorectal Cancer: a Meta-analysis

  • Han, Ye (Department of General Surgery, The First Affiliated Hospital of Soochow University) ;
  • Xue, Xiao-Feng (Department of General Surgery, The First Affiliated Hospital of Soochow University) ;
  • Shen, Hu-Gang (Department of General Surgery, Kunshan Hospital of Traditional Chinese Medicine) ;
  • Guo, Xiao-Bo (Department of Gastrointestinal Surgery, Provincial Hospital Affiliated to Shandong University) ;
  • Wang, Xu (Department of General Surgery, The First Affiliated Hospital of Soochow University) ;
  • Yuan, Bin (Department of General Surgery, The First Affiliated Hospital of Soochow University) ;
  • Guo, Xing-Po (Department of General Surgery, The First Affiliated Hospital of Soochow University) ;
  • Kuang, Yu-Ting (Department of General Surgery, The First Affiliated Hospital of Soochow University) ;
  • Zhi, Qiao-Ming (Department of General Surgery, The First Affiliated Hospital of Soochow University) ;
  • Zhao, Hong (Department of General Surgery, The First Affiliated Hospital of Soochow University)
  • Published : 2014.06.15


Objective: Beclin-1 has recently been observed as an essential marker of autophagy in several cancers. However, the prognostic role of Beclin-1 in colorectal neoplasia remains controversial. Our study aimed to evaluate the potential association between Beclin-1 expression and the outcome of colorectal cancer patients. Materials and Methods: All related studies were systematically searched in Pubmed, Embase, Springer and Chinese National Knowledge Infrastructure databases (CNKI), and then a meta-analysis was performed to determine the association of Beclin-1 expression with clinical outcomes. Finally, a total of 6 articles were included in our analysis. Results: Our data showed that high Beclin-1 expression in patients with CRC was associated with poor prognosis in terms of tumor distant metastasis (OR=2.090, 95%CI=1.061-4.119, p=0.033) and overall survival (RR=1.422, 95%CI=1.032-1.959, p=0.031). However, we did not found any correlation between Beclin-1 over-expression and tumor differentiation (OR=1.711, 95%CI=0.920-3.183, p=0.090). In addition, there was no evidence of publication bias as suggested by Egger's tests for tumor distant metastasis (p=1.000), differentiation (p=1.000) and OS (p=0.308). Conclusions: Our present meta-analysis indicated that elevated Beclin-1 expression iss associated with tumor metastasis and a poor prognosis in patients with CRC. Beclin-1 might serve as an efficient prognostic indicator in CRC, and could be a new molecular target in CRC therapy.


  1. Chen Z, Li Y, Zhang C, et al (2013). Downregulation of Beclin 1 and impairment of autophagy in a small population of colorectal cancer. Dig Dis Sci, 58, 2887-94.
  2. Ahn CH, Jeong EG, Lee JW, et al (2007). Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS, 115, 1344-9.
  3. Cao Y, Klionsky DJ (2007). Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res, 17, 839-49.
  4. Geng QR, Xu DZ, He LJ, et al (2012). Beclin-1 expression is a significant predictor of survival in patients with lymph node-positive gastric cancer. PLoS One, 7, 45968.
  5. Guo GF, Jiang WQ, Zhang B, et al (2011). Autophagy-related proteins Beclin-1 and LC3 predict cetuximab efficacy in advanced colorectal cancer. World J Gastroenterol, 17, 4779-86.
  6. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
  7. Kekelidze M, D'Errico L, Pansini M, Tyndall A, Hohmann J (2013). Colorectal cancer: current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation. World J Gastroenterol, 19, 8502-14.
  8. Khiewkhern S, Promthet S, Sukprasert A, Eunhpinitpong W, Bradshaw P (2013). Effectiveness of aromatherapy with light thai massage for cellular immunity improvement in colorectal cancer patients receiving chemotherapy. Asian Pac J Cancer Prev, 14, 3903-7.
  9. Kim HS, Lee SH, Do SI, et al (2011). Clinicopathologic correlation of beclin-1 expression in pancreatic ductal adenocarcinoma. Pathol Res Pract, 207, 247-52.
  10. Koukourakis MI, Giatromanolaki A, Sivridis E, et al (2010). Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia. Br J Cancer, 103, 1209-14.
  11. Klionsky DJ, Emr SD (2000). Autophagy as a regulated pathway of cellular degradation. Science, 290, 1717-21.
  12. Koneri K, Goi T, Yamaguchi A (2003) Analysis of cell cycle inhibition by novel tumor suppressor gene Beclin 1 in human colon cancer cells. Nihon Rinsho, 61, 247-51.
  13. Koneri K, Goi T, Hirono Y, Katayama K, Yamaguchi A (2007). Beclin 1 gene inhibits tumor growth in colon cancer cell lines. Anticancer Res, 27, 1453-7.
  14. Li BX, Li CY, Peng RQ, et al (2009). The expression of beclin 1 is associated with favorable prognosis in stage IIIB colon cancers. Autophagy, 5, 303-6.
  15. Maiuri MC, Tasdemir E, Criollo A, et al (2009). Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ, 16, 87-93.
  16. Miracco C, Cosci E, Oliveri G, et al (2007). Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours. Int J Oncol, 30, 429-36.
  17. Mizushima N, Levine B, Cuervo AM, Klionsky DJ (2008). Autophagy fights disease through cellular self-digestion. Nature, 451, 1069-75.
  18. Myung Park J, Huang S, Wu TT, Foster NR, Sinicrope FA (2013). Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy. Cancer Biol Ther, 14, 100-7.
  19. Parmar MK, Torri V, Stewart L (1998). Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med, 17, 2815-34.<2815::AID-SIM110>3.0.CO;2-8
  20. Xia P, Wang JJ, Zhao BB, Song CL (2013). The role of beclin-1 expression in patients with gastric cancer: a meta-analysis. Tumour Biol, 34, 3303-7.
  21. Song H, Xia SL, Liao C, et al (2004). Genes encoding Pir51, Beclin 1, RbAp48 and aldolase b are up or down-regulated in human primary hepatocellular carcinoma. World J Gastroenterol, 10, 509-13.
  22. Sui YQ, Feng YZ (2012). Expreesion and clinical significance of autophage-ralated genes LC3, Beclin-1 and apoptosis-related genes p53, BCL-2 in colorectal carcinoma. J Clin Exp pathol, 28, 282-6.
  23. Tong GX, Chai J, Cheng J, et al (2014). Diagnostic value of rectal bleeding in predicting colorectal cancer: a systematic review. Asian Pac J Cancer Prev, 15, 1015-21.
  24. Zafar SY, Malin JL, Grambow SC, et al (2013). Chemotherapy use and patient treatment preferences in advanced colorectal cancer: a prospective cohort study. Cancer, 119, 854-62.
  25. Zeng X, Overmeyer JH, Maltese WA (2006) Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking. J Cell Sci, 119, 259-70.
  26. Zhang HQ, He B, Fang N, et al (2013). Autophagy inhibition sensitizes cisplatin cytotoxicity in human gastric cancer cell line SGC7901. Asian Pac J Cancer Prev, 14, 4685-8.
  27. Zois CE, Koukourakis MI (2009). Radiation-induced autophagy in normal and cancer cells: towards novel cytoprotection and radio-sensitization policies? Autophagy, 5, 442-50.

Cited by

  1. Expression of Beclin Family Proteins Is Associated with Tumor Progression in Oral Cancer vol.10, pp.10, 2015,
  2. Expression pattern of autophagy-related markers in non-metastatic clear cell renal cell carcinoma: association with disease recurrence following radical nephrectomy vol.141, pp.9, 2015,
  3. Aldose Reductase Inhibitor Fidarestat as a Promising Drug Targeting Autophagy in Colorectal Carcinoma: a Pilot Study vol.16, pp.12, 2015,
  4. Effect of Autophagy-Related Beclin1 on Sensitivity of Cisplatin-Resistant Ovarian Cancer Cells to Chemotherapeutic Agents vol.16, pp.7, 2015,
  5. Relationships of Colorectal Cancer with Dietary Factors and Public Health Indicators: an Ecological Study vol.16, pp.9, 2015,
  6. Role of autophagy-related protein expression in patients with rectal cancer treated with neoadjuvant chemoradiotherapy vol.16, pp.1, 2016,
  7. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta-analysis vol.16, pp.18, 2016,
  8. Role of the pretreatment 18F-fluorodeoxyglucose positron emission tomography maximal standardized uptake value in predicting outcomes of colon liver metastases and that value's association with Beclin-1 expression vol.11, pp.2, 2017,
  9. Clinical Applications of Autophagy Proteins in Cancer: From Potential Targets to Biomarkers vol.18, pp.7, 2017,
  10. Intestinal Autophagy and Its Pharmacological Control in Inflammatory Bowel Disease vol.7, pp.1664-3224, 2017,